![](/img/cover-not-exists.png)
466PPhase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD
Aparicio, T, Darut Jouve, A, Khemissa, F, Montérymard, C, Artru, P, Cany, L, Romano, O, Valenza, B, Le Foll, C, Delbaldo, C, Falandry, C, Duluc, M, Rinaldi, Y, Legoux, J L, Ben Abdelghani, M, Assenat,Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy281.014
Date:
October, 2018
File:
PDF, 79 KB
english, 2018